AVITA Medical (RCEL) Return on Invested Capital (2019 - 2025)
AVITA Medical's Return on Invested Capital history spans 7 years, with the latest figure at 0.33% for Q4 2025.
- For Q4 2025, Return on Invested Capital rose 767.0% year-over-year to 0.33%; the TTM value through Dec 2025 reached 0.33%, up 767.0%, while the annual FY2025 figure was 0.66%, 184.0% up from the prior year.
- Return on Invested Capital reached 0.33% in Q4 2025 per RCEL's latest filing, down from 0.12% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.54% in Q2 2025 to a low of 8.0% in Q4 2024.
- Average Return on Invested Capital over 5 years is 1.0%, with a median of 0.33% recorded in 2025.
- Peak YoY movement for Return on Invested Capital: crashed -787bps in 2024, then soared 767bps in 2025.
- A 5-year view of Return on Invested Capital shows it stood at 0.2% in 2021, then tumbled by -62bps to 0.32% in 2022, then skyrocketed by 59bps to 0.13% in 2023, then tumbled by -5983bps to 8.0% in 2024, then surged by 96bps to 0.33% in 2025.
- Per Business Quant, the three most recent readings for RCEL's Return on Invested Capital are 0.33% (Q4 2025), 0.12% (Q3 2025), and 0.54% (Q2 2025).